
Two new studies showing contradictory results when it comes to omega 3 fatty acids and cardiovascular disease risk.
Study #1
Researchers compared the heart health and exercise capacity of 98 patients randomly divided between a control group receiving a placebo supplement and the test group supplementing 850-882 milligrams of the omega 3 fatty acids DHA and EPA. All study participants were diagnosed with early stage heart failure.

Hitting
Being active while you work can reduce your risk for heart disease just as much as exercising in your leisure time.
An FDA panel consisting of 20 experts voted 13 to 7 in favor of approving the weight loss drug Contrave, with an abstention that additional studies be conducted related to heart risks. Safety concerns were considered, but it was determined that the pros of the medication outweighed the cons. Two weight loss drugs were rejected by the FDA panel just this past October due to safety concerns.


